Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Calithera begins Phase II trial of CB-839 to treat renal cell carcinoma

Go Top